ClinConnect ClinConnect Logo
Search / Trial NCT06368713

Exercise Improves Gastrointestinal Function in Peritoneal Dialysis Patients

Launched by SICHUAN ACADEMY OF MEDICAL SCIENCES · Apr 11, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Peritoneal Dialysis Exercise Intervention Gastrointestinal Function Telehealth

ClinConnect Summary

This clinical trial is looking at how exercise can help improve the gastrointestinal function, or how well the digestive system works, in patients who are on peritoneal dialysis. Peritoneal dialysis is a treatment for people with chronic kidney disease that helps filter waste from the blood when the kidneys aren't functioning well. The researchers want to see if being more active can enhance quality of life for these patients.

To participate in the study, patients need to be between 18 and 65 years old and have been on peritoneal dialysis for more than three months. They also need to own and know how to use a smartphone, as this may be part of the study's activities. However, individuals with certain health issues, like severe heart or lung problems, will not be eligible to join. Participants can expect to engage in an exercise program designed to see if it makes a positive difference in their health and well-being while providing valuable information for future treatments.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients must have undergone peritoneal dialysis for more than 3 months.
  • 2. Age between 18 and 65 years.
  • 3. Possession of a smartphone and proficiency in its usage.
  • 4. Willingness to provide voluntary informed consent by signing the consent form.
  • Exclusion Criteria:
  • 1. Recent systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg, or systolic blood pressure ≤90 mmHg or diastolic blood pressure ≤60 mmHg within the past week.
  • 2. Presence of severe cardiovascular diseases, including but not limited to:
  • Heart failure classified as New York Heart Association (NYHA) functional grade IV-V.
  • Severe arrhythmias such as third-degree atrioventricular block, sick sinus syndrome, paroxysmal supraventricular tachycardia, or ventricular tachycardia.
  • Unstable angina.
  • Pulmonary arterial hypertension with pulmonary arterial pressure ≥25 mmHg.
  • Severe pericardial effusion, valve stenosis, hypertrophic cardiomyopathy, or aortic dissection.
  • 3. Severe pulmonary diseases, including but not limited to:
  • Severe chronic obstructive pulmonary disease (COPD).
  • Pulmonary embolism.
  • Lung cancer.
  • Severe pulmonary infection.
  • 4. Presence of deep venous thrombosis.
  • 5. Severe neurological, muscular, bone, or joint diseases that hinder compliance with exercise.
  • 6. Participation in other concurrent exercise programs.

About Sichuan Academy Of Medical Sciences

The Sichuan Academy of Medical Sciences is a renowned research institution dedicated to advancing healthcare through innovative clinical research and development. With a strong emphasis on translational medicine, the Academy collaborates with various healthcare stakeholders to conduct rigorous clinical trials that aim to enhance treatment efficacy and patient outcomes. Its multidisciplinary team is committed to fostering scientific advancements and addressing critical health challenges, thereby contributing significantly to the global medical community. Through a combination of cutting-edge technology and expert knowledge, the Sichuan Academy of Medical Sciences plays a pivotal role in shaping the future of medical research and public health initiatives.

Locations

Chengdu, Sichuan, China

Patients applied

0 patients applied

Trial Officials

Jin Chen, Doctor

Principal Investigator

Sichuan Academy of Medical Sciences , University of Electronic Science and Technology of China,

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported